Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
-
Randomized Controlled Trial Multicenter Study Comparative Study
Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
To examine the tolerability and adverse events reported in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). ⋯ Acetazolamide appears to have an acceptable safety profile at dosages up to 4 g/d in the treatment of idiopathic intracranial hypertension. The majority of participants in the Idiopathic Intracranial Hypertension Treatment Trial were able to tolerate acetazolamide above 1 g/d for 6 months.
-
Randomized Controlled Trial
The idiopathic intracranial hypertension treatment trial: design considerations and methods.
The objectives of this study were to present the rationale for the main aspects of the study design and describe the trial methodology for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). ⋯ The IIHTT is the first randomized, double-masked placebo-controlled trial to study the effectiveness of medical treatment for patients with IIH.